- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04227353
Healthy Eating and Active Lifestyle After Bowel Cancer: HEAL ABC (HEALABC)
Healthy Eating and Active Lifestyle After Bowel Cancer - HEAL ABC Workbook: Development and Feasibility Trial
Trial Design:
This is a feasibility randomised controlled trial.
Aim:
The study aims to test the Healthy Eating and Active Lifestyle After Bowel Cancer - HEAL ABC intervention and HEAL ABC resources for feasibility and will inform a future definitive randomised controlled trial (RCT).
Objectives:
- Is it practical to run HEAL ABC study as a definitive randomised controlled trial?
- Adherence to intervention, motivations, barriers and facilitators of CRC survivors to follow HEAL ABC.
Study Population:
Colorectal cancer survivors who completed surgery and/or active treatment.
Intervention:
The intervention group will use HEAL ABC resource with supportive telephone calls every two weeks during the intervention period and once a month during the follow up period.
Control:
Participants follow standard care recommendations.
Timing and duration:
3 months intervention with 6 months follow up period
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Investigators were awarded a grant to develop a lifestyle resource called HEAL ABC - the Healthy Eating and Active Lifestyle After Bowel Cancer. This resource is based on prevention guidelines of World Cancer Research Fund and American Institute of Cancer Research. The resource was developed in cooperation with a psychologist and so has incorporated behaviour change theory. Investigators organised focused groups with patients and healthcare professionals, and amended the resource based on their feedback.
In this study, investigators will test the HEAL ABC resource and the HEAL ABC intervention for its practicality before further studies will be conducted.
HEAL ABC consists of 10 booklets and supportive materials. The order for using the booklets is not specified. Participants will be assigned their first booklet based on the one they perceive to be the easiest for setting an incremental goal and achieving it. This means the participant starts with the booklet of the highest self-efficacy and after the participant achieves successful behaviour change, he or she can move more confidently to the next booklet. During the follow up period, participants will use the follow up booklet which helps them to continue with changes they have made and encourage them to set a new goals.
Participants in the intervention group will receive a supportive telephone call every two weeks during the intervention period (three months) and once a month during the six months follow up.
Participants allocated to the control group will given information about publicly available resources on healthy lifestyle recommendations. No additional support will be provided.
Primary Question/Objective:
Is it feasible to run a definitive RCT to determine the effectiveness of HEAL ABC? This study will address questions around suitability and practicality of using the HEAL ABC resource and the ability to run an intervention in relation to adherence, recruitment, retention rates and the ability to collect relevant data.
Secondary Question/Objective:
Adherence to intervention and the motivations, barriers and facilitators of CRC survivors to follow HEAL ABC.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Manchester, United Kingdom, M13 9WL
- Manchester University NHS Foundation Trust
-
Manchester, United Kingdom, M139PL
- The University of Manchester
-
-
Great Manchester
-
Manchester, Great Manchester, United Kingdom, M6 8HD
- Salford Royal NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults, age ≥18
- Minimum 12 weeks post-surgery and/or active treatment
- Completed all active anti-cancer treatments, including surgery, radiotherapy or chemotherapy
- Body mass index ≥20 kg/m2 and no previous unintentional weight loss ≥5% of body weight in the previous six months.
- Identified as living an unhealthy lifestyle based on current recommendations - follow less than four of the WCRF/AICR recommendations on eligibility questionnaire
- Ability to work with computer, smart phone or tablet.
- Able to give informed consent.
Exclusion Criteria:
- Receiving treatment for malignancy.
- Secondary malignancy.
- Having short bowel syndrome, Crohn's disease, ulcerative colitis, diverticulitis or jejunostomy (due to requirement for a very specific diet).
- Previous stroke, congested cardiac failure or oedema.
- Hepatic or renal failure
- Less than 12 weeks post-surgery or active treatment.
- Meeting the requirements of a healthy lifestyle (follow four or more of the WCRF/AICR recommendations).
- Being on any therapeutic diets, multiple food intolerances or allergies.
- Unplanned weight loss of ≥10% in the previous 3-6 months.
- Cannot read or communicate in English (due to resource constraints of this PhD study).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HEAL ABC
Participants allocated to the intervention will be encouraged to follow the HEAL ABC resources in order to make a healthy eating and active lifestyle change.
This will be achieved by setting specific goal(s) and by making concrete plan(s) to implement changes in their everyday life.
Interventions will be delivered in the form of written resources that will guide participants.
Supportive phone calls using motivational interviewing techniques will be provided to participants every two weeks to encourage lifestyle changes.
|
Participants will be assigned their first booklet based on the one they perceive to be the easiest for setting an incremental goal and achieving it.
After the participant achieves successful behaviour change, he or she can move more confidently to the next booklet.
Support will be provided every two weeks over the phone for 12 weeks.
During the follow-up period, participants will use the follow-up booklet which helps them to continue with changes they have made and encourage them to set new goals.
|
|
No Intervention: HEALTH
Participants allocated to the control group will be referred to publicly available resources on healthy lifestyle recommendations but will not receive any additional support.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to intervention
Time Frame: 3 months
|
Assessed as adherence to WCRF/AICR guidelines by using a scoring system for nutrition and physical activity guideline adherence developed by McCullough and colleagues.
Number of goals set and number of changes implemented in everyday life during the 3 months intervention.
|
3 months
|
|
Adherence to intervention
Time Frame: 6 months
|
Assessed as adherence to WCRF/AICR guidelines by using a scoring system for nutrition and physical activity guideline adherence developed by McCullough and colleagues.
Number of goals set and number of changes implemented in everyday life during the 6 months follow up.
|
6 months
|
|
Recruitment rates
Time Frame: 3 months
|
Cumulative recruitment against target rate each month.
|
3 months
|
|
Recruitment rates
Time Frame: 6 months
|
Cumulative recruitment against target rate each month.
|
6 months
|
|
Retention rates
Time Frame: 3 months
|
Calculated as the number of participants who completed the study divided by the number of participants randomised.
|
3 months
|
|
Retention rates
Time Frame: 6 months
|
Calculated as the number of participants who completed the study divided by the number of participants randomised.
|
6 months
|
|
Acceptability of the intervention
Time Frame: 3 months
|
This will be qualitatively assessed through in depth interviews with a subset of the trial participants.
|
3 months
|
|
Acceptability of the intervention
Time Frame: 6 months
|
This will be qualitatively assessed through in depth interviews with a subset of the trial participants.
|
6 months
|
|
Data completion rates
Time Frame: 3 months
|
Completeness of collected data will be assessed for all time points (% missing).
|
3 months
|
|
Data completion rates
Time Frame: 6 months
|
Completeness of collected data will be assessed for all time points (% missing).
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in participants' experience, motivation, barriers and facilitators to use HEAL ABC resources and follow the intervention
Time Frame: 3 months and 6 months
|
Qualitatively assessed with in depth interviews.
|
3 months and 6 months
|
|
Change in behaviour
Time Frame: Baseline, 3 months and 6 months
|
The health action process approach (HAPA) questionnaires, previously used in publications investigating changes in HAPA constructs in lifestyle interventions.
A 5 point Likert scale will be used for each question.
Minimum score is 15 and maximum score is 75.
Higher score is better score.
|
Baseline, 3 months and 6 months
|
|
Change in dietary intake
Time Frame: Baseline, 3 months and 6 months
|
Three day dietary assessment.
Participants will complete prospectively food diary during the day and enter all foods and drinks consumed into online system for dietary assessment - INTAKE24.
|
Baseline, 3 months and 6 months
|
|
Change in BMI
Time Frame: Baseline, 3 months and 6 months
|
Body weight [kg] and height [m] to calculate body mass index
|
Baseline, 3 months and 6 months
|
|
Change in waist to hip ratio
Time Frame: Baseline, 3 months and 6 months
|
waist circumference [cm] and hip circumference [cm] to calculate waist to hip ratio
|
Baseline, 3 months and 6 months
|
|
Change in body composition (BIA)
Time Frame: Baseline, 3 months and 6 months
|
lean mass [%] and fat mass [%] using bio-impedance machine
|
Baseline, 3 months and 6 months
|
|
Change in body composition (CT scan)
Time Frame: Baseline, 3 months and 6 months
|
muscle mass [cm2] and fat mass [cm2]using CT scans body composition analysis
|
Baseline, 3 months and 6 months
|
|
Change in physical activity
Time Frame: Baseline, 3 months and 6 months
|
Global Physical Activity Questionnaire is used to assess the metabolic equivalent (MET) based on Global Physical Activity Questionnaire Analysis Guide: https://www.who.int/ncds/surveillance/steps/resources/GPAQ_Analysis_Guide.pdf
|
Baseline, 3 months and 6 months
|
|
Change in step count
Time Frame: Baseline, 3 months and 6 months
|
pedometer
|
Baseline, 3 months and 6 months
|
|
Patients' socio-demographic characteristics
Time Frame: Baseline
|
age, gender, marital status, occupation, education, income, ethnicity, smoking status and number of supplements used
|
Baseline
|
|
Contact with primary and secondary healthcare services
Time Frame: 6 months
|
The Healthcare Resource Use Questionnaire - questionnaire was developed by a health economist for the EU funded project 'PreventIT' (2016-2018, grant number 689238) responding to the Horizon 2020, Personalised Health and Care call PHC-21: Advancing active and healthy aging with ICT: Early risk detection and intervention.
There is no set score - questionnaire is used to estimate the costs associated with different healthcare services used.
|
6 months
|
|
Mortality
Time Frame: 6 months
|
Patient's medical records
|
6 months
|
|
Morbidity
Time Frame: 6 months
|
Patient's medical records
|
6 months
|
|
Change in Quality of life
Time Frame: Baseline, 3 months and 6 months
|
SF-12 questionnaire - 12 questions, total score can range from 0 to 100 (sore zero indicates the lowest level of health and 100 indicates the highest level of health).
|
Baseline, 3 months and 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jana Sremanakova, University of Manchester
Publications and helpful links
General Publications
- Sremanakova J, Jones D, Cooke R, Burden S. Exploring Views of Healthcare Professionals, Researchers, and People Living with and beyond Colorectal Cancer on a Healthy-Eating and Active Lifestyle Resource. Nutrients. 2019 Oct 16;11(10):2482. doi: 10.3390/nu11102482.
- Burden S, Jones DJ, Sremanakova J, Sowerbutts AM, Lal S, Pilling M, Todd C. Dietary interventions for adult cancer survivors. Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD011287. doi: 10.1002/14651858.CD011287.pub2.
- Burden S, Sremanakova J, Jones D, Todd C. Dietary interventions for cancer survivors. Proc Nutr Soc. 2019 Feb;78(1):135-145. doi: 10.1017/S0029665118002690. Epub 2018 Dec 19.
- Wright SJ, Gibson D, Eden M, Lal S, Todd C, Ness A, Burden S. What are colorectal cancer survivors' preferences for dietary advice? A best-worst discrete choice experiment. J Cancer Surviv. 2017 Dec;11(6):782-790. doi: 10.1007/s11764-017-0615-2. Epub 2017 Apr 20.
- Aubrey V, Hon Y, Shaw C, Burden S. Healthy eating interventions in adults living with and beyond colorectal cancer: a systematic review. J Hum Nutr Diet. 2019 Aug;32(4):501-511. doi: 10.1111/jhn.12651. Epub 2019 Apr 3.
- Sremanakova J, Sowerbutts AM, Todd C, Cooke R, Burden S. Healthy Eating and Active Lifestyle After Bowel Cancer (HEAL ABC): feasibility randomised controlled trial protocol. Pilot Feasibility Stud. 2020 Nov 13;6(1):176. doi: 10.1186/s40814-020-00721-y.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NHS001653
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Thomas...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...CompletedColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States
Clinical Trials on HEAL ABC
-
University of Maryland, College ParkAmerican Cancer Society, Inc.; Community Ministry of Prince George's County; Access...CompletedBreast Cancer | Colorectal Cancer | Prostate CancerUnited States
-
King's College LondonUniversity College, LondonCompletedType2 DiabetesUnited Kingdom
-
University Hospital, LinkoepingCompleted
-
Duke UniversityCompleted
-
National Taiwan University HospitalCompletedLifestyle Risk Reduction | Elderly Adults | Community DwellingTaiwan
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)CompletedDepressive Symptoms | Anxiety SymptomsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Completed
-
University of AlbertaNutricia Foundation; Canadian National Transplant Research ProgramActive, not recruitingHepatic Encephalopathy | Cirrhosis, LiverCanada
-
SoundHealCounty of San Luis Obispo - Probation Department; County of San Luis Obispo...RecruitingAnxiety Disorders | Substance Use Disorders | Stress Disorders | Emotional Dysregulation | Mental Health Disorders | Therapeutic Alliance | Depression DisorderUnited States
-
IRCCS Eugenio MedeaRecruitingAcquired Brain Injury | Pragmatic Communication DisorderItaly